GE HealthCare /
SOFIE Biosciences
GE HealthCare agrees to buy PET drug maker SOFIE Biosciences from Trilantic
Source for the buyer, seller and target: GE HealthCare
For the buyer, seller and target.
“Chicago, IL — October 5, 2026 — GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash.”
Published 5 Oct 2026
Open the sourceWhat happened
GE HealthCare has agreed to buy SOFIE Biosciences, a U.S. contract manufacturer of PET radiopharmaceuticals, from Trilantic North America for $945 million in cash, the company said on October 5, 2026. The deal is expected to close in the first half of 2027, subject to regulatory approvals. [01]
SOFIE Biosciences runs 15 CMO sites with 21 cyclotrons in the U.S. and will become part of GE HealthCare's PDx segment. Co-founder, President and CEO Patrick Phelps credited Trilantic North America's support for a big expansion in its capabilities and scale. [01]
The source
Everything on this page comes from the source below, quoted word for word.
GE HealthCare agrees to buy PET drug maker SOFIE Biosciences from Trilantic
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“GE HealthCare agrees to buy PET drug maker SOFIE Biosciences from Trilantic GE HealthCare has agreed to buy SOFIE Biosciences, a U.S. contract manufacturer of PET radiopharmaceuticals, from Trilantic North America for…”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
Deal Web
Every firm and person on this deal, and how they connect. Open any name to see their other deals.
Agreement signed · GE HealthCare agreed to acquire SOFIE Biosciences from Trilantic North America (Agreement signed, published 5 Oct 2026).
Announced 5 Oct 2026- Announced
- Published by GE HealthCare
Deal Web as a list
- GE HealthCare (Buyer) agreed to acquire this deal. GE HealthCare: 1 deal on Carrywatch.
- SOFIE Biosciences (Target) target this deal. SOFIE Biosciences: 1 deal on Carrywatch.
- Trilantic North America (Seller) selling this deal. Trilantic North America: 1 deal on Carrywatch.
By email · Weekly